ADVANCED MALIGNANT NEOPLASM
Clinical trials for ADVANCED MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug trial halted early – what we know
Disease control TerminatedThis early-stage study tested a new drug called AUR106 in 21 adults with advanced cancers (lung, stomach, bladder, kidney, colon, or esophagus) that had come back or spread. The main goal was to find a safe dose and check how the drug moves through the body. The study was stopped…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 26, 2026 05:13 UTC
-
New drug cocktail trial targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase trial tested combinations of drugs (bevacizumab, temsirolimus, valproic acid, or cetuximab) in 154 adults with advanced cancers or certain non-cancerous diseases that are progressive and life-limiting. The main goal was to find the safest doses and understand sid…
Matched conditions: ADVANCED MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:06 UTC